IP Library Granted Patent US 9,622,914
Granted Patent B2
US 9,622,914 · App. 13/571,860 · Granted Apr 18, 2017

Reduced-pressure systems and methods employing a leak-detection member

Inventors: Christopher Brian Locke (Bournemouth, GB); Timothy Mark Robinson (Basingstoke, GB); Aidan Marcus Tout (Wiltshire, GB); Justin Alexander Long (San Antonio, TX)
Assignee: KCI Licensing, Inc.
A61F13/00068A61F13/0216A61M1/009A61F2013/0094A61F2013/0097A61F2013/00174A61F2013/00536A61F2013/00795A61F2013/00846A61F2013/00885A61F2013/00948A61M1/0088A61M2205/15
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,622,914
App. No.
13/571,860
Granted
Apr 18, 2017
Kind
B2
Abstract

Systems, methods, and apparatus are provided for detecting leaks in systems for treating a patient with reduced pressure. In one instance, a system includes a distribution manifold for disposing proximate to the tissue site and a sealing member for disposing over the distribution manifold and at least a portion of intact epidermis of the patient. The sealing member has at least a portion that is substantially transparent. The system further includes a reduced-pressure source associated with the distribution manifold for providing reduced pressure to the distribution manifold and a leak-detection member sized and configured to substantially surround the distribution manifold. The leak-detection member includes a detection material that develops a color contrast when a portion is exposed to air and a portion is not exposed to air. The leak detection member works with even low flow systems. Other systems, methods, and apparatus are presented.

Claims (62)

1. A system for treating a tissue site on a patient with reduced pressure, the system comprising:

a distribution manifold for disposing proximate to the tissue site;

a sealing member for disposing over the distribution manifold, wherein the sealing member comprises at least a portion that is substantially transparent, the sealing member configured to form a sealed space having the distribution manifold therein;

a reduced-pressure source associated with the distribution manifold for providing reduced pressure to the distribution manifold; and

a leak detection ring having an inner and outer circumference, the inner circumference configured to be disposed outboard of the distribution manifold, the leak detection ring being formed from a detection material configured to develop a color contrast in response to a leak of the sealing member, the detection material being reactive to air and becoming fluorescent when exposed to a diction tool in an activated state and changing fluorescence when exposed to oxygen.

2. The system of claim 1 , wherein the leak detection ring comprises one or more members concentric with the distribution manifold.

3. The system of claim 1 , wherein the detection material further comprises a hydrophilic adhesive disposed in the leak detection ring on a tissue facing side of the sealing member.

4. A system for treating a tissue site on a patient with reduced pressure, the system comprising:

a distribution manifold for disposing proximate to the tissue site;

a sealing member for disposing over the distribution manifold, wherein the sealing member comprises at least a portion that is substantially transparent, the sealing member configured to form a sealed space having the distribution manifold therein;

a reduced-pressure source associated with the distribution manifold for providing reduced pressure to the distribution manifold;

a leak detection ring having an inner and outer circumference, the inner circumference configured to be disposed outboard of the distribution manifold, the leak detection ring being formed from a detection material configured to develop a color contrast in response to a leak of the sealing member; and

wherein the detection material comprises a first agent covering at least a portion of a tissue-facing side of the sealing member, and a skin-preparation fluid forming the leak detection ring and having a second agent, the first agent of the sealing member and the second agent of the skin-preparation fluid forming a contact color when combined that is indicative of contact between the first agent and the second agent, the contact color providing the color contrast with portions of the first agent not in contact with the second agent.

5. The system of claim 1 , wherein the detection material is selected from at least one of the following: methylene blue,

N-phenylanthranilic acid, titanium dioxide, and glycerol.

6. A method for providing reduced-pressure treatment to a tissue site on a patient, the method comprising:

disposing a distribution manifold proximate to the tissue site;

disposing at least one ring having an inner and outer circumference formed from a detection material around the distribution manifold and the tissue site onto at least one of an epidermis of the patient outboard of the tissue site and onto a tissue-facing side of a sealing member, so that the inner circumference is outboard of the distribution manifold, the at least one ring comprising one or more curved members;

covering the distribution manifold and at least partially covering the at least one ring with the sealing member to seal the distribution manifold in a sealed space, wherein the sealing member has at least a portion that is substantially transparent;

providing reduced pressure to the distribution manifold; and

identifying a color contrast in the detection material indicative of a leak in the sealed space.

7. A method for providing reduced-pressure treatment to a tissue site on a patient, the method comprising:

disposing a distribution manifold proximate to the tissue site;

disposing at least one ring having an inner and outer circumference formed from a detection material around the distribution manifold and the tissue, so that the inner circumference is outboard of the distribution manifold by applying a liquid onto an intact epidermis of the patient outboard of the tissue site;

covering the distribution manifold and at least partially covering the at least one ring with a sealing member to seal the distribution manifold in a sealed space, wherein the sealing member has at least a portion that is substantially transparent;

providing reduced pressure to the distribution manifold; and

identifying a color contrast in the detection material indicative of a leak in the sealed space.

8. The method of claim 6 , wherein the detection material reacts to air.

9. A method for providing reduced-pressure treatment to a tissue site on a patient, the method comprising:

disposing a distribution manifold proximate to the tissue site;

disposing at least one ring having an inner and outer circumference formed from a detection material around the distribution manifold and the tissue site, so that the inner circumference is outboard of the distribution manifold;

covering the distribution manifold and at least partially covering the at least one ring with a sealing member to seal the distribution manifold in a sealed space, wherein the sealing member has at least a portion that is substantially transparent;

providing reduced pressure to the distribution manifold;

identifying a color contrast in the detection material indicative of a leak in the sealed space by:

exposing the detection material to a detection tool so that the detection material fluoresces; and

identifying areas of the detection material having differing fluorescence.

10. A method for providing reduced-pressure treatment to a tissue site on a patient, the method comprising:

disposing a distribution manifold proximate to the tissue site;

disposing at least one ring having an inner and outer circumference formed from a detection material around the distribution manifold and the tissue site, so that the inner circumference is outboard of the distribution manifold wherein the detection material reacts to a challenge gas;

covering the distribution manifold and at least partially covering the at least one ring with a sealing member to seal the distribution manifold in a sealed space, wherein the sealing member has at least a portion that is substantially transparent;

providing reduced pressure to the distribution manifold;

identifying a color contrast in the detection material indicative of a leak in the sealed space by

spraying the challenge gas onto the sealing member.

11. A method for providing reduced-pressure treatment to a tissue site on a patient, the method comprising:

disposing a distribution manifold proximate to the tissue site;

disposing at least one ring having an inner and outer circumference formed from a detection material around the distribution manifold and the tissue site, so that the inner circumference is outboard of the distribution manifold by disposing a first agent on a tissue-facing side of a sealing member, and disposing a skin-preparation fluid having a second agent on an intact epidermis of the patient, wherein the first agent of the sealing member and the second agent of the skin-preparation fluid form a contact color when combined that is indicative of contact between the first agent and the second agent and sealing of the sealed space;

covering the distribution manifold and at least partially covering the at least one ring with the sealing member to seal the distribution manifold in a sealed space, wherein the sealing member has at least a portion that is substantially transparent;

providing reduced pressure to the distribution manifold;

identifying a color contrast in the detection material indicative of a leak in the sealed space.

12. The method of claim 6 , wherein disposing the at least one ring comprises applying a hydrophilic adhesive to a tissue-facing side of the sealing member.

13. A system for treating a tissue site on a patient with reduced pressure, the system comprising:

a distribution manifold for disposing proximate to the tissue site;

a sealing member for disposing over the distribution manifold, wherein the sealing member comprises at least a portion that is substantially transparent, the sealing member configured to form a sealed space having the distribution manifold therein;

a reduced-pressure source associated with the distribution manifold for providing reduced pressure to the distribution manifold; and

a leak detection ring having an inner and outer circumference, the inner circumference configured to be disposed outboard of the distribution manifold, the leak detection ring being formed from a detection material configured to develop a color contrast in response to a leak of the sealing member and the detection material reacts to a challenge gas sprayed onto the sealing member by a challenge gas distributor.

14. The system of claim 13 , wherein the challenge gas is carbon dioxide.

15. A system for treating a tissue site on a patient with reduced pressure, the system comprising:

a distribution manifold for disposing proximate to the tissue site;

a sealing member for disposing over the distribution manifold, wherein the sealing member comprises at least a portion that is substantially transparent, the sealing member configured to form a sealed space having the distribution manifold therein;

a reduced-pressure source associated with the distribution manifold for providing reduced pressure to the distribution manifold; and

a leak detection ring having an inner and outer circumference, the inner circumference configured to be disposed outboard of the distribution manifold, the leak detection ring being formed from a detection material configured to develop a color contrast in response to a leak of the sealing member and wherein the detection material comprises a skin-preparation fluid reactive to air.

16. The system of claim 1 , wherein the leak detection ring is configured to be disposed between the sealing member and the tissue site.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066432/0376 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064718/0544 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 23, 2013
From: LOCKE, CHRISTOPHER BRIAN; ROBINSON, TIMOTHY MARK; TOUT, AIDAN MARCUS; LONG, JUSTIN ALEXANDER
To: KCI LICENSING, INC.
Reel/Frame 030860/0831 →
Continuity (2)
Provisional Application 61534566 · Sep 14, 2011
Related Publication 20130066285A1 · Mar 14, 2013